-
1
-
-
0032894774
-
RET proto-oncogene in the development of human cancer
-
Eng C. RET proto-oncogene in the development of human cancer. J Clin Oncol 1999; 17: 380-93.
-
(1999)
J Clin Oncol
, vol.17
, pp. 380-393
-
-
Eng, C.1
-
2
-
-
0034693757
-
The RET proto-oncogene in human cancers
-
Jhiang SM. The RET proto-oncogene in human cancers. Oncogene 2000; 19; 5590-7.
-
(2000)
Oncogene
, vol.19
, pp. 5590-5597
-
-
Jhiang, S.M.1
-
3
-
-
0029827559
-
Neurturin, a relative of glial-cell-line-derived neurotrophic factor
-
Kotzbauer PT, Lampe PA, Heuckeroth RO, et al. Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature 1996; 384: 467-70.
-
(1996)
Nature
, vol.384
, pp. 467-470
-
-
Kotzbauer, P.T.1
Lampe, P.A.2
Heuckeroth, R.O.3
-
4
-
-
0030949872
-
RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma
-
Marsh DJ, Mulligan LM, Eng C. RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma. Horm Res 1997; 47: 168-78.
-
(1997)
Horm Res
, vol.47
, pp. 168-178
-
-
Marsh, D.J.1
Mulligan, L.M.2
Eng, C.3
-
5
-
-
0028199074
-
Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC
-
Mulligan LM, Eng C, Healey CS, et al. Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nat Genet 1994; 6: 70-4.
-
(1994)
Nat Genet
, vol.6
, pp. 70-74
-
-
Mulligan, L.M.1
Eng, C.2
Healey, C.S.3
-
6
-
-
4644256817
-
The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET Mutation Consortium analysis
-
Eng C, Clayton D, Schuffenecker I, et al. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET Mutation Consortium analysis. J Am Med Assoc 1996; 276: 1575-9.
-
(1996)
J Am Med Assoc
, vol.276
, pp. 1575-1579
-
-
Eng, C.1
Clayton, D.2
Schuffenecker, I.3
-
7
-
-
0030896418
-
Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2, related sporadic tumors and Hirschprung disease
-
Eng C, Mulluiga LM. Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2, related sporadic tumors and Hirschprung disease. Hum Mutat 1997; 9: 97-109.
-
(1997)
Hum Mutat
, vol.9
, pp. 97-109
-
-
Eng, C.1
Mulluiga, L.M.2
-
8
-
-
0031733399
-
Somatic mutations in the RET protooncogene in Japanese and Chinese sporadic medullary thyroid carcinomas
-
Shan L, Nakamur M, Nakamura Y, et al. Somatic mutations in the RET protooncogene in Japanese and Chinese sporadic medullary thyroid carcinomas. Jpn J Cancer Res 1998; 89: 883-96.
-
(1998)
Jpn J Cancer Res
, vol.89
, pp. 883-896
-
-
Shan, L.1
Nakamur, M.2
Nakamura, Y.3
-
9
-
-
10144242640
-
Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL, in sporadic pheochromocytoma revelas involvement of these genes in only a minority of cases
-
Hofstra RMW, Stelwagen T, Stulp RP, et al. Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL, in sporadic pheochromocytoma revelas involvement of these genes in only a minority of cases. J Clin Endocrinol Metab 1996; 81: 2881-4.
-
(1996)
J Clin Endocrinol Metab
, vol.81
, pp. 2881-2884
-
-
Hofstra, R.M.W.1
Stelwagen, T.2
Stulp, R.P.3
-
10
-
-
0030019642
-
Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma
-
Marsh DJ, Learoyd DL, Andrew SD, et al. Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma. Clin Endocrinol 1996; 44: 249-57.
-
(1996)
Clin Endocrinol
, vol.44
, pp. 249-257
-
-
Marsh, D.J.1
Learoyd, D.L.2
Andrew, S.D.3
-
11
-
-
0033921316
-
RET is expressed but not mutated in extra-adrenal paragangliomas
-
de Krijger RR, van der Harst E, Muletta-Feuer S, et al. RET is expressed but not mutated in extra-adrenal paragangliomas. J Pathol 2000; 191: 264-8.
-
(2000)
J Pathol
, vol.191
, pp. 264-268
-
-
De Krijger, R.R.1
Van Der Harst, E.2
Muletta-Feuer, S.3
-
12
-
-
0031792082
-
Morphological diversity in malignant melanoma: The potential use of microdissection and the polymerase chain reaction for diagnosis
-
Quezado MM, Abati AD, Albuquerque AV, Wilson J, Merino MJ, Filie AC. Morphological diversity in malignant melanoma: the potential use of microdissection and the polymerase chain reaction for diagnosis. Mod Pathol 1998; 11: 1010-5.
-
(1998)
Mod Pathol
, vol.11
, pp. 1010-1015
-
-
Quezado, M.M.1
Abati, A.D.2
Albuquerque, A.V.3
Wilson, J.4
Merino, M.J.5
Filie, A.C.6
-
13
-
-
0032908708
-
Expression of interleukin 6 (IL-6) correlates with estrogen receptor in human breast carcinoma
-
Fontanini G, Campani D, Roncella M, et al. Expression of interleukin 6 (IL-6) correlates with estrogen receptor in human breast carcinoma. Br J Cancer 1999; 80: 579-84.
-
(1999)
Br J Cancer
, vol.80
, pp. 579-584
-
-
Fontanini, G.1
Campani, D.2
Roncella, M.3
-
14
-
-
0028914683
-
Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B
-
Santoro M, Carlomagno F, Romano A, et al. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science 1995; 267: 381-3.
-
(1995)
Science
, vol.267
, pp. 381-383
-
-
Santoro, M.1
Carlomagno, F.2
Romano, A.3
-
15
-
-
0028838086
-
Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations
-
Asai N, Iwashita T, Matsuyama M, Takahashi M. Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations. Mol Cell Biol 1995; 3: 1613-9.
-
(1995)
Mol Cell Biol
, vol.3
, pp. 1613-1619
-
-
Asai, N.1
Iwashita, T.2
Matsuyama, M.3
Takahashi, M.4
-
16
-
-
0028838075
-
A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC
-
Eng C, Smith DP, Mulligan LM. et al. A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. Oncogene 1995; 10: 509-13.
-
(1995)
Oncogene
, vol.10
, pp. 509-513
-
-
Eng, C.1
Smith, D.P.2
Mulligan, L.M.3
-
17
-
-
0029002147
-
RET mutations in exons 13 and 14 of FMTC patients
-
Bolino A, Schuffenecker I, Luo Y, et al. RET mutations in exons 13 and 14 of FMTC patients. Oncogene 1995; 10: 2415-9.
-
(1995)
Oncogene
, vol.10
, pp. 2415-2419
-
-
Bolino, A.1
Schuffenecker, I.2
Luo, Y.3
-
18
-
-
0027231568
-
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
-
Mulligan LM, Kwok JB, Healey CS, et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993; 363: 458-60.
-
(1993)
Nature
, vol.363
, pp. 458-460
-
-
Mulligan, L.M.1
Kwok, J.B.2
Healey, C.S.3
-
19
-
-
0027965639
-
DNA polymorphism and conditions for SSCP analysis of the 20 exons of the ret proto-oncogene
-
Ceccherini I, Hofstra RMW, Luo Y, et al. DNA polymorphism and conditions for SSCP analysis of the 20 exons of the ret proto-oncogene. Oncogene 1994; 9: 3025-9.
-
(1994)
Oncogene
, vol.9
, pp. 3025-3029
-
-
Ceccherini, I.1
Hofstra, R.M.W.2
Luo, Y.3
-
20
-
-
0028838578
-
Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas
-
Zedenius J, Larsson C, Bergholm U, et al. Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas. J Clin Endocrinol Metab 1995; 80: 3088-90.
-
(1995)
J Clin Endocrinol Metab
, vol.80
, pp. 3088-3090
-
-
Zedenius, J.1
Larsson, C.2
Bergholm, U.3
-
21
-
-
0033934460
-
Absence of somatic RET mutation in sporadic parathyroid tumors and hyperplasia secondary to uremia and absence of somatic MEN1 gene mutation in MEN 2A-associated hyperplasia
-
Uchino S, Noguchi S, Nagatomo M, et al. Absence of somatic RET mutation in sporadic parathyroid tumors and hyperplasia secondary to uremia and absence of somatic MEN1 gene mutation in MEN 2A-associated hyperplasia. Biomed Pharmacother 2000; 54 (Suppl. 1): 100-3.
-
(2000)
Biomed Pharmacother
, vol.54
, Issue.SUPPL. 1
, pp. 100-103
-
-
Uchino, S.1
Noguchi, S.2
Nagatomo, M.3
-
22
-
-
0029932083
-
Absence of mutations at codon 768 of the RET proto-oncogene in sporadic and hereditary pheochromocytomas
-
Yoshimoto K, Kimura T, Tanaka C, Moritani M, Iwahana H, Itakura M. Absence of mutations at codon 768 of the RET proto-oncogene in sporadic and hereditary pheochromocytomas. Endocr J 1996; 43: 109-14.
-
(1996)
Endocr J
, vol.43
, pp. 109-114
-
-
Yoshimoto, K.1
Kimura, T.2
Tanaka, C.3
Moritani, M.4
Iwahana, H.5
Itakura, M.6
-
23
-
-
0030154859
-
The RET proto-oncogene in sporadic pheochromocytomas
-
Takaya K, Yoshimasa T, Arai H, et al. The RET proto-oncogene in sporadic pheochromocytomas. Int Med 1996; 35: 449-52.
-
(1996)
Int Med
, vol.35
, pp. 449-452
-
-
Takaya, K.1
Yoshimasa, T.2
Arai, H.3
-
24
-
-
0035293279
-
Genetic aspects of pheochromocytoma
-
Koch CA, Vortmeye AO, Huang SC, Alesci S, Zhuang Z, Pacak K. Genetic aspects of pheochromocytoma. Endocr Regul 2001; 35: 45-52.
-
(2001)
Endocr Regul
, vol.35
, pp. 45-52
-
-
Koch, C.A.1
Vortmeye, A.O.2
Huang, S.C.3
Alesci, S.4
Zhuang, Z.5
Pacak, K.6
-
25
-
-
0034485464
-
Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas
-
Bender BU, Gutsche M, Glasker S, et al. Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas. J Clin Endocrinol Metab 2000; 85: 4568-74.
-
(2000)
J Clin Endocrinol Metab
, vol.85
, pp. 4568-4574
-
-
Bender, B.U.1
Gutsche, M.2
Glasker, S.3
-
26
-
-
0030804006
-
Genetic predisposition to pheochromocytoma: Analysis of candidate genes GDNF, RET and VHL
-
Woodward ER, Eng C, McMahon R, et al. Genetic predisposition to pheochromocytoma: analysis of candidate genes GDNF, RET and VHL. Hum Mol Genet 1997; 6: 1051-6.
-
(1997)
Hum Mol Genet
, vol.6
, pp. 1051-1056
-
-
Woodward, E.R.1
Eng, C.2
McMahon, R.3
-
27
-
-
10144242640
-
Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases
-
Hofstra RMW, Stelwagen T, Stulp RP, et al. Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases. J Clin Endocrinol Metab 1996; 81: 2881-4.
-
(1996)
J Clin Endocrinol Metab
, vol.81
, pp. 2881-2884
-
-
Hofstra, R.M.W.1
Stelwagen, T.2
Stulp, R.P.3
|